Search results
Hace 1 día · Anne Wojcicki. Thank you, Joe. Fiscal 2024 was a productive yet transitional year at 23andMe. The conclusion in July of the exclusive period of our discovery and development collaboration ...
Hace 1 día · ME. 8.01%. 23andMe Holding Co. (ME) disclosed a strategic review to enhance shareholder value and a potential acquisition offer from CEO Anne Wojcicki during its Fiscal Year 2024 Fourth Quarter ...
Hace 1 día · Anne Wojcicki destacó la integración de Lemonaid para crear un servicio integral de prevención del bienestar. Se centra en aprovechar la amplia base de datos genéticos para aplicaciones ...
Hace 1 día · 23andMe Holding Co. (ME) disclosed a strategic review to enhance shareholder value and a potential acquisition offer from CEO Anne Wojcicki during its Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results Conference Call. The company reported a revenue downturn due to the end of a key collaboration and lower consumer services sales ...
Hace 2 días · “The Company had a productive fourth quarter and solid end to the year, continuing to add value for members of 23andMe+ and advancing our clinical stage assets,” said Anne Wojcicki, Co-Founder & CEO of 23andMe. “We continue to work to build value for customers and shareholders and are looking forward to a transformative FY2025.”
Hace 1 día · DNA testing firm 23andMe Holding Co. reported fourth-quarter revenue that beat Wall Street estimates on Thursday even as the firm’s sales were well below the same period last year.
Hace 2 días · But just as remarkable were the health care and health tech A-Listers who just showed up as summit attendees to listen and learn from their peers — like 23AndMe’s Anne Wojcicki.
